Article Text
Abstract
Objective To assess the use of two-channel electroencephalographical (EEG) recordings for predicting adverse neurodevelopmental outcome (death or Bayley II mental developmental index/psychomotor developmental index < 70) in extremely preterm infants and to determine the relationship between quantitative continuity measures and a specialist neurophysiologist assessment of the same EEG segment for predicting outcome.
Design Observational study.
Setting The study was conducted in a neonatal intensive care unit.
Patients Preterm infants born <29 weeks' gestation.
Interventions Two-channel EEGs using the reBRM2 monitor (BrainZ Instruments, Auckland, New Zealand) within 48 h of delivery. One-hour segments were analysed, blinded to the clinical outcome, by off-line quantitative analysis of continuity and a review of the raw EEG by a neurophysiologist.
Main outcome measures Developmental assessment at a median of 15 months' corrected age.
Results 76 infants had an EEG within 48 h of delivery and a developmental assessment. The analysed segment of the EEG was obtained at 24 (3–48) h of age (median (range)). The neurophysiologist's assessment was a better predictor of adverse outcome than the continuity measures (positive predictive value 95% CI 75 (54% to 96%) vs 41 (22% to 60) at 25-µV threshold, negative predictive value 88 (80% to 96%) vs 84 (74% to 94%) and positive likelihood ratio 9.0 (3.2 to 24.6) vs 2.0 (1.2 to 3.6)). All the infants with definite seizures identified by the neurophysiologist had poor outcomes.
Conclusions Modified cot-side EEG has potential to assist with identification of extremely preterm infants at risk for adverse neurodevelopmental outcomes. However, analysis by a neurophysiologist performed better than the currently available continuity analyses.
Statistics from Altmetric.com
Footnotes
-
Funding CRW received a University of Auckland Senior Health Research Scholarship during the period of data collection. The reBRM EEG machines were leased from BrainZ Instruments using a University of Auckland Staff Research Grant awarded to MRB.
-
Competing interests None.
-
Ethics approval This study was conducted with the approval of the Auckland Ethics Committee X and The University of Auckland ethics committee, and the Auckland District Health Board granted ethical approval.
-
Provenance and peer review Not commissioned; externally peer reviewed.